Abstract：【Objective】To investigate the efficacy and safety of Stanford accelerated intelligent neuromodulation therapy (SNT) combined with medication in the treatment of first-episode depressive disorder.【Methods】A total of 56 patients with depressive disorder hospitalized in the Hunan Brain Hospital from December 2022 to December 2023 were selected and divided into SNT combined with drug therapy group (SNT group) or repetitive transcranial magnetic stimulation (rTMS) combined with drug therapy group (rTMS group) according to random number table method, with 28 cases in each group. After 1 week and 4 weeks of treatment, 17-item Hamilton Depression Scale (HAMD17) and Hamilton Anxiety Scale (HAMA) were used to evaluate the depression and anxiety symptoms of the patients, and adverse events were recorded by self-designed adverse event record sheet.【Results】After 1 week of treatment and 4 weeks of treatment, HAMD17 scores and HAMA scores in two groups were lower than before treatment, and HAMD17 scores and HAMA scores in the SNT group were lower than those of the rTMS group after 1 week of treatment, with statistical significance (P>0.05). After 1 week of treatment, the effective rate of HAMD17 score and HAMA score in the rTMS group was 36%, and that in the SNT group was 100%. The clinical effective rate in the SNT group was higher than that in the rTMS group, with statistical significance (P<0.05). After 4 weeks of treatment, the effective rates of HAMD17 score and HAMA score in the rTMS group were 96% and 100%, respectively, while those in the SNT group were 100%. There was no statistical significance in the effective rates between the two groups (P>0.05).【Conclusion】SNT and rTMS are safe and effective in the treatment of first-episode depressive disorder. SNT model can significantly improve depression and anxiety symptoms faster than rTMS.
王艺卓, 朱强, 罗银利, 李莉, 刘丽妮, 杨栋. 斯坦福加速智能神经调节疗法联合药物治疗首发抑郁障碍患者的疗效及安全性*[J]. 医学临床研究, 2024, 41(11): 1672-1675.
WANG Yizhuo, ZHU Qiang, LUO Yinli, et al. Efficacy and Safety of Stanford Accelerated Intelligent Neuromodulation Therapy in Combination with Medication for First-episode Depressive Disorder. JOURNAL OF CLINICAL RESEARCH, 2024, 41(11): 1672-1675.
[1] HUANG Y, WANG Y, WANG H, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study[J].Lancet Psychiatry,2019, 6(3): 211-224. [2] AVISSAR M, POWELL F, ILIEVA I, et al. Functional connectivity of the left DLPFC to striatum predicts treatment response of depression to TMS[J].Brain Stimul,2017, 10(5): 919-925. [3] MiTRA A, RAICHLE M E, GEOLY A D, et al. Targeted neurostimulation reverses a spatiotemporal biomarker of treatment-resistant depression[J].Proc Natl Acad Sci U S A,2023, 120(21): e2218958120. [4] COLE E J, STIMPSON K H, BENTZLEY B S, et al. Stanford accelerated intelligent neuromodulation therapy for treatment-resistant depression[J].Am J Psychiatry,2020, 177(8): 716-726. [5] COLE E J, PHILLIPS A L, BENTZLEY B S, et al. Stanford Neuromodulation Therapy (SNT): a double-blind randomized controlled trial[J].Am J Psychiatry,2022, 179(2): 132-141. [6] PERERA T, GEORGE M S, GRAMMER G, et al. The clinical TMS society consensus review and treatment recommendations for TMS therapy for major depressive disorder[J].Brain Stimul,2016, 9(3): 336-346. [7] MUTZ J, EDGCUMBE D R, BRUNONI A R, et al. Efficacy and acceptability of non-invasive brain stimulation for the treatment of adult unipolar and bipolar depression: a systematic review and meta-analysis of randomised sham-controlled trials[J].Neurosci Biobehav Rev,2018, 92: 291-303. [8] IGLESIAS A H. Transcranial magnetic stimulation as treatment in multiple neurologic conditions[J].Curr Neurol Neurosci Rep,2020, 20(1): 1. [9] FERRARELLI F, PHILLIPS M L. Examining and modulating neural circuits in psychiatric disorders with transcranial magnetic stimulation and electroencephalography: present practices and future developments[J].Am J Psychiatry,2021,178(5): 400-413. [10] CAO G, HARRIS K M. Augmenting saturated LTP by broadly spaced episodes of theta-burst stimulation in hippocampal area CA1 of adult rats and mice[J].J Neurophysiol,2014, 112(8): 1916-1924. [11] NETTEKOVEN C, VOLZ L J, KUTSCHA M, et al. Dose-dependent effects of theta burst rTMS on cortical excitability and resting-state connectivity of the human motor system[J].J Neurosci,2014, 34(20): 6849-6859. [12] ALKHASLI I, SAKREIDA K, MOTTAGHY F M, et al. Modulation of fronto-striatal functional connectivity using transcranial magnetic stimulation[J].Front Hum Neurosci,2019, 13: 190. [13] LI C T, CHEN M H, JUAN C H, et al. Efficacy of prefrontal theta-burst stimulation in refractory depression: a randomized sham-controlled study[J].Brain,2014, 137(Pt 7): 2088-2098. [14] BLUMBERGER D M, VILA-RODRIGUEZ F, THORPE K E, et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial[J].Lancet,2018, 391(10131): 1683.
2024, Vol. 41 
